Erdafitinib-associated Subretinal Fluid in a 75-Year-Old Man With Vitreomacular Traction
{{output}}
Fibroblast growth factor receptor (FGFR) inhibitors are increasingly used in cancer therapy but cause ocular side effects, including subretinal fluid (SRF). Baseline vitreomacular traction (VMT) may predispose patients to drug-induced SRF. A 75-year-old man wi... ...
